Revised SPC: Kigabeq (vigabatrin) 100 and 500 mg soluble tablets

Insomnia and alopecia (frequency “common”) and reduced visual acuity (frequency “not known”) have been to SPC as adverse effects.

Source:

electronic Medicines compendium